Treating Prostate Cancer by Antibody–Drug Conjugates

Prostate cancer is the most frequent malignancy in the worldwide male population; it is also one of the most common among all the leading cancer-related death causes. In the last two decades, the therapeutic scenario of metastatic castration-resistant prostate cancer has been enriched by the use of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Mol Sci
Main Authors: Rosellini, Matteo, Santoni, Matteo, Mollica, Veronica, Rizzo, Alessandro, Cimadamore, Alessia, Scarpelli, Marina, Storti, Nadia, Battelli, Nicola, Montironi, Rodolfo, Massari, Francesco
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2021
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7913806/
https://ncbi.nlm.nih.gov/pubmed/33557050
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms22041551
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados